Lantheus Holdings, Inc. ( LNTH) - Key Metrics
LNTH Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $5.96 | $1.15 | $3.34 | $3.25 |
| 2026Q1 | $5.83 | $1.83 | $1.93 | $1.88 |
| 2025Q4 | $6.20 | $0.82 | $1.38 | $1.24 |
| 2025Q3 | $5.71 | $0.41 | $1.57 | $1.41 |
| 2025Q2 | $5.52 | $1.15 | $1.27 | $1.08 |
LNTH Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | 24.12 |
| 2026Q1 | 0% | 10.36 |
| 2025Q4 | 0% | 20.29 |
| 2025Q3 | 0% | 31.27 |
| 2025Q2 | 0% | 17.80 |
LNTH Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 2.93% | 0% |
| 2026Q1 | 2.48% | 0% |
| 2025Q4 | 1.86% | 0% |
| 2025Q3 | 2.75% | 0% |
| 2025Q2 | 1.31% | 0% |
LNTH
Price: $100
52 week price:
Payout Ratio Range:
Earnings Per Share: 4.18 USD
P/E Ratio: 24.16
Exchange: NGM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 24390
Ebitda: 17.5 millionMarket Capitalization: 6.5 billion